MYD88 and Alzheimer disease: TLR4 signaling cascade, recruited and interacted with Myd88 that resulted in the MAPK and NF-κB activation upon LPS administration, has been reported to be highly associated with the response of neuroinflammation and involved in the development of AD and other Neurodegenerative disorder (26).